Genetic loss of Tmprss6 alters terminal erythroid differentiation in a mouse model of β-thalassemia intermedia

Míreanna Comhchosúla

• Short-term administration of JAK2 inhibitors reduces splenomegaly in mouse models of β-thalassemia intermedia and major
  le: Casu, Carla, et al.
  Foilsithe: (2018)
• Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice
  le: Guo, Shuling, et al.
  Foilsithe: (2013)
• Tmprss6 is a genetic modifier of the Hfe-hemochromatosis phenotype in mice
  le: Finberg, Karin E., et al.
  Foilsithe: (2011)
• Combination of Tmprss6- ASO and the iron chelator deferiprone improves erythropoiesis and reduces iron overload in a mouse model of beta-thalassemia intermedia
  le: Casu, Carla, et al.
  Foilsithe: (2016)
• β-Thalassemia: HiJAKing Ineffective Erythropoiesis and Iron Overload
  le: Melchiori, Luca, et al.
  Foilsithe: (2010)